Evidence map›Paper›PMID 30074154›Full record

ArticleCurrent medical science2018

Bioinformatics Analysis of Genes and Pathways of CD11b

Dong Sun, Xin Wan, Bin-Bin Pan, Qing Sun, Xiao-Bing Ji, Feng Zhang, Hao Zhang, Chang-Chun Cao

Open access · hybridAbstract read
In one paragraph

Article in Current medical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dong SunDepartment of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Xin WanDepartment of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Bin-Bin PanDepartment of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Qing SunDepartment of Nephrology, The Affiliated Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, China.
Xiao-Bing JiDepartment of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Feng ZhangDepartment of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Hao ZhangDepartment of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Chang-Chun CaoDepartment of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China. caochangchun@njmu.edu.cn.
Nanjing Medical University · CNGaochun People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury (AKI), which could induce the poor prognosis. The purpose of this study was to characterize the molecular mechanism of the functional changes of CDllb+/Ly6C

Indexed as

Gene Regulatory NetworksProtein Interaction MapsTranscriptomeAntigens, LyCD11b AntigenHumansKidneyMacrophagesReperfusion InjuryAntigens, LyCD11b Antigendifferentially expressed genesfunctional enrichment analysismacrophageprotein-protein interactionrenal ischemia-reperfiision injuryseries test of cluster

Identifiers

PMID30074154
PMCPMC7089064
OpenAlexW2793423923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.